Written by Jessica Bartlett
Telehealth company American Well said it closed a $194 million funding round as it seeks to bolster its technology and platform during the pandemic.
Inclusive of the recent Series C raise, the Boston-based company, also known as Amwell, has raised half a billion in funding rounds. The most recent round included early investors and strategic partners, including Allianz X and Takeda Pharmaceutical Co. Ltd.
“The past two months have accelerated telehealth by more than two years,” said Ido Schoenberg, CEO of Amwell. “We intend to build upon this momentum to transform healthcare with digital care delivery.”
The funding will be invested in the company’s technology, which connects not only patients with providers for one-off video urgent care visits, but also helps connect doctors and specialists with their own patients. The technology is the backend to many platforms that exist on provider webpages throughout the country
Read more here.